Study genetic and blood markers in people with inherited intellectual disability
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study looks at genetic-related and blood/biologic markers in people with an inherited (genetic) intellectual disability. The goal is to better understand these differences and how they might relate to the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have an intellectual disability caused by genetics (an inherited/genetic origin)
- You are coming to the Institut Jérôme Lejeune for a consultation
- Your parent or legal representative received the study information, understood it, and signed consent for research samples
- You are covered by a social security plan (have social security benefits)
- You are not pregnant, and you are not currently nursing (breastfeeding)
- You are not currently unable to participate due to being detained by a judicial or administrative decision
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genetics and gene-regulation (how genes turn on and off) differ between close family members who have different Down syndrome status. Researchers hope the findings will help explain why Down syndrome outcomes can vary even in very closely related people.
This study looks at genes that might change how intellectual disability appears in patients. It uses genetic data already collected to find new clues.
This study uses advanced genetic tests to find the cause of severe intellectual disability or related developmental disorders when standard tests found nothing. If you or your child qualify, the study may provide a clearer diagnosis and help guide care.
This research study aims to better understand Down syndrome by collecting health information, family history, and sometimes brain imaging or sleep data from children and adults with Down syndrome and their families. The goal is to advance knowledge that could improve health and development for people with Down syndrome.
This trial uses a new DNA sequencing method that reads long stretches of DNA to find genetic causes of rare diseases. It is for people who have intellectual development disorders or albinism and have not yet gotten a clear genetic diagnosis from standard tests.
This study looks at genetic (DNA) information to understand mental health crises in youth with intellectual and developmental disabilities. It may help doctors learn why these crises happen and improve how future families are supported.
Hear when a new Down Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.